Brutec Pharma Private Limited, a active private limited company, was established on 11 January 2018 in Thodupuzha, Kerala, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U36999KL2018PTC051695. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Bhaskaran Gopal Vinodh (Whole-Time Director), Ramees Riyas (Managing Director), Rayees Riyas (Additional Director). Past directors included Thanelil Muhammadu Meeran, Bhaskaran Gopal Vinodh, Ramees Riyas. It holds ₹1.20 M open charges and ₹1.20 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Brutec Pharma,Thodupuzha East P.O., Mangattukavala, Near Josh Travels,, Thodupuzha, Kerala, 685585.
U36999KL2018PTC051695
051695
11 January 2018
₹0.50 M
₹0.50 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Brutec Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhaskaran Gopal Vinodh | Whole-Time Director | 01 Dec 2024 | Current |
| Ramees Riyas | Managing Director | 15 Jul 2019 | Current |
| Rayees Riyas | Additional Director | 11 Nov 2024 | Current |
| Aboobaker Puthuparambil Ismail | Director | 11 Jan 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jul 2019 | Past |
| Pramod Abcsdd | Additional Director | 01 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2019 | Past |
| Pramod Abcsdd | Managing Director | 10 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Brutec Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 64.35% decrease. The company also saw a substantial improvement in profitability, with a 503.59% increase in profit. The company's net worth Soared by an impressive increase of 20.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Brutec Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,200,000.00
₹1,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Nov 2019 | The South Indian Bank Limited | ₹1.20 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Brutec Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Brutec Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brutec Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Bhaskaran Gopal Vinodh was appointed as a Whole-time director was appointed as a Whole-time director on 01 Dec 2024 & has been associated with this company since 11 months 30 days . was documented.
Progress on A charge registered on 04 Nov 2019 via Charge ID 100311376 with The South Indian Bank Limited was fully satisfied on 14 Nov 2024. was documented.
Progress on Rayees Riyas was appointed as a Additional Director was appointed as a Additional Director on 11 Nov 2024 & has been associated with this company since 1 year 19 days . was documented.
The activity Brutec Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Brutec Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
The activity A charge with The South Indian Bank Limited of Rs. 1.20 M registered on 04 Nov 2019 with Charge ID 100311376 was modified on 04 Nov 2020. was completed.
The CIN of Brutec Pharma Private Limited is U36999KL2018PTC051695.
Brutec Pharma Private Limited is headquartered at Brutec Pharma,Thodupuzha East P.O., Mangattukavala, Near Josh Travels,, Thodupuzha, Kerala, 685585.
Brutec Pharma Private Limited was incorporated on 11 January 2018.
The current directors of Brutec Pharma Private Limited are
The primary industry of Brutec Pharma Private Limited is Manufacturing.
Brutec Pharma Private Limited is unlisted.
The authorized capital of Brutec Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX